NCT01540539View on ClinicalTrials.gov

Intravenous/Subcutaneous FIH Study of REGN1154 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Healthy Volunteers
Interventions
DRUG

REGN1154 or placebo

Participants will receive active drug or placebo

Trial Locations (1)

Unknown

Melbourne

All Listed Sponsors
lead

Regeneron Pharmaceuticals

INDUSTRY

NCT01540539 - Intravenous/Subcutaneous FIH Study of REGN1154 in Healthy Volunteers | Biotech Hunter | Biotech Hunter